HealthCap is a family of venture capital funds, investing globally in life sciences. and is one of the largest life science specialized VC's in Europe.
HealthCap is a European venture capital firm investing solely and globally in life sciences. Having raised more than EUR 900 million in six funds since 1996, HealthCap has backed and built more than 100 companies, taken more than 30 companies public and done numerous trade sales. HealthCap’s investment strategy focuses on working... Read more »
HealthCap is a family of venture capital funds, investing globally in life sciences. and is one of the largest life science specialized VC's in Europe.
HealthCap is a European venture capital firm investing solely and globally in life sciences. Having raised more than EUR 900 million in six funds since 1996, HealthCap has backed and built more than 100 companies, taken more than 30 companies public and done numerous trade sales. HealthCap’s investment strategy focuses on working with diseases with high unmet medical needs and therapies that have the potential to be transformative and change medical practice, and the lives of patients suffering these conditions.
- See more at: http://www.healthcap.eu/the-funds/the-investment-approach/#sthash.CKdZct...
HealthCap is a European venture
capital firm investing solely and globally in life sciences. Having
raised more than EUR 900 million in six funds since 1996, HealthCap has
backed and built more than 100 companies, taken more than 30 companies
public and done numerous trade sales. HealthCap’s investment strategy
focuses on working with diseases with high unmet medical needs and
therapies that have the potential to be transformative and change
medical practice, and the lives of patients suffering these conditions.
Over the years our
companies have developed more than 20 pharmaceutical products to market
approval, many of which are breakthrough therapies helping patients with
life-threatening diseases to live better lives. In addition, HealthCap
companies have brought more than 40 innovative medical device products
to market. These products have generated significant value to many
stakeholders, including patients, physicians, society as well as to
investors.
.
- See more at: http://www.healthcap.eu/the-funds/the-investment-approach/#sthash.CKdZct...
Collapse
